Core Laboratories (CLB) Q3 2025 Earnings Call Summary

1Key Financial Results and Metrics

Revenue: $134.5 million, up 3% sequentially but flat year-over-year.

Service Revenue: $101.1 million, up 5% sequentially and over 2% year-over-year.

Product Sales: $33.4 million, down slightly from the previous quarter and down 6% year-over-year.

Operating Income (ex items): $16.6 million, up from $14.5 million in Q2, with an EBIT margin of over 12%.

Net Income (ex items): $10.2 million, up 15% sequentially but down 14% year-over-year.

Earnings Per Share (EPS): $0.22 (ex items), up from $0.19 in Q2 but down from $0.25 year-over-year.

Free Cash Flow: $6.5 million after capital expenditures of $2 million.

2Strategic Updates and Business Highlights

Core Lab continues to focus on technology investments to solve client problems and capitalize on global opportunities.

The Reservoir Description segment saw revenue growth of over 2% due to steady demand for rock and fluid analysis.

The Production Enhancement segment experienced a 6% revenue increase, driven by demand for completion diagnostic services.

The company repurchased over 462,000 shares, returning $5 million to shareholders.

Core Lab is committed to maintaining a lean organization and returning excess free cash to shareholders.

3Forward Guidance and Outlook

For Q4 2025, Core projects total revenue between $132 million and $136 million, with operating income expected to range from $14 million to $16.1 million.

Reservoir Description: revenue is projected to be between $88 million and $90 million, while Production Enhancement is expected to range from $44 million to $46 million.

EPS for Q4 is anticipated to be between $0.18 and $0.22.

The company maintains a positive long-term outlook, driven by expected growth in global crude oil demand.

4Bad News, Challenges, or Points of Concern

Geopolitical Risks: Ongoing international conflicts and sanctions create uncertainty in demand for laboratory services related to crude oil.

Commodity Price Volatility: Tariffs and fluctuating commodity prices may impact demand and profitability, especially in the U.S. onshore market.

Flat U.S. Service Revenue: Service revenue in the U.S. remained flat sequentially and decreased nearly 4% year-over-year, indicating potential market saturation or weakness.

Product Sales Decline: Product sales decreased due to lower completion activity in the U.S. onshore market.

5Notable Q&A Insights

Management expressed optimism about future activity levels, particularly in the Middle East, South Atlantic margin, and West Africa, with expectations for increased international investment.

The recent acquisition of Solintec was discussed, highlighting a unique earn-out structure that aligns incentives between Core Lab and the seller.

Clients are generally optimistic about higher activity levels in the coming years, particularly in international markets, indicating a potential shift away from reliance on U.S. production growth. In summary, while Core Laboratories demonstrated solid financial performance in Q3 2025, challenges related to geopolitical risks, commodity price volatility, and a flat U.S. market persist. However, the company remains strategically positioned for growth through technological advancements and international market opportunities.